{
    "Orphapacket": {
        "ORPHApacketId": "306686",
        "creationDate": "2020-12-03 15:53:15",
        "version": "1.3.6 / 4.1.7 [2020-04-17] (orientdb version)",
        "copyright": "Orphanet (c) 2020",
        "ORPHAcode": "306686",
        "Label": "Delayed encephalopathy due to carbon monoxide poisoning",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_306686",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "Delayed encephalopathy due to CO poisoning"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare neurologic disease characterized by delayed onset of encephalopathy typically within a few weeks after acute carbon monoxide poisoning. The most common symptoms are cognitive impairment personality changes and movement disorder including parkinsonism among others. Prognosis is good with a high rate of spontaneous recovery within a year."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "306679",
                        "Label": "Rare parkinsonian syndrome due to intoxication"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "556508",
                        "Label": "Rare disorder due to poisoning"
                    }
                ]
            }
        ],
        "Phenotypes": [
            {
                "Phenotype": {
                    "HPOId": "HP:0000708",
                    "HPOTerm": "Behavioral abnormality",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002354",
                    "HPOTerm": "Memory impairment",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002518",
                    "HPOTerm": "Abnormality of the periventricular white matter",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0012706",
                    "HPOTerm": "Elevated brain choline level by MRS",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0012708",
                    "HPOTerm": "Reduced brain N-acetyl aspartate level by MRS",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002063",
                    "HPOTerm": "Rigidity",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002067",
                    "HPOTerm": "Bradykinesia",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002817",
                    "HPOTerm": "Abnormality of the upper limb",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0004673",
                    "HPOTerm": "Decreased facial expression",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            }
        ]
    }
}